$1.27
At close: Apr 15, 9:20 AM EDT
$1.25
-0.02-1.57%
After Hours: 9:20 AM EDT
Comments
Loading...
Taysha Gene Therapies Stock Price, Quotes and Forecasts
TSHANASDAQ
Taysha Gene Therapies (TSHA) Forecast
NewsEarningsTaysha Gene Therapies (TSHA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Taysha Gene Therapies Stock Price, Quotes and Forecasts | NASDAQ:TSHA | Benzinga
Explore Taysha Gene Therapies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TSHA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Taysha Gene Therapies (TSHA) stock?
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Who are Taysha Gene Therapies (TSHA) competitors?
Other companies in Taysha Gene Therapies’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the forecast, or price target, for Taysha Gene Therapies (TSHA) stock?
Taysha Gene Therapies has a consensus price target of $5.87.
What is the current price for Taysha Gene Therapies (TSHA)?
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $1.25 last updated April 15, 2025 at 9:20 AM EDT.
Does Taysha Gene Therapies (TSHA) pay a dividend?
There are no upcoming dividends for Taysha Gene Therapies.
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Taysha Gene Therapies (TSHA) going to split?
There is no upcoming split for Taysha Gene Therapies.
What sector and industry does Taysha Gene Therapies (TSHA) operate in?
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.